Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Poly Medicure Ltd Regulatory Filings 2021

Mar 31, 2021

60661_rns_2021-03-31_7ec8e194-cc35-41f3-b851-6e38bfcbb319.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Poly Medicure Limited

Regd. Office : 232 -B, 3'' Floor, Okhla Industrial Estate, Phase-Ill, New Delhi - 110020 (INDIA) T: +9 1-ll -33550700,47317000, F:+91-l l -26321894, 26321839 E: [email protected] W: polymedicure.com GIN: L40300DL1995PLC066923

31.03.2021

Scrip Code: - 531768

The Manager, BSE Limited, Department of Corporate Services, Phirozee Jeejeebhoy Towers, Dalal Street, Mumbai- 400001.

Scrip Code:- POL YMED

The Manager National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1-Block-G Sandra Kurla Complex, Bandra(E), Mumbai-400051.

Subject:- Intimation of Closure of Trading Window

Dear Sir/Madam,

It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01 /2019- 20 dated 02.04.2019 and NSE letter ref no: NSE/CML/20 I 9/11 dated 02.04.2019 read with Company's Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Thursday, the 1 st April, 2021 till the end of 48 hours after the declaration of Financial Results for the quarter and year ended on 31 st March, 2021.

The date of the Board Meeting to consider the above financial results would be intimated to the Stock Exchange in due course.

You are hereby requested to please take the above information on your records.

Thanking You, For Poly Medicure Limited

Company Secretary 0